This is a phase II open-label study evaluating the pharmacokinetics and pharmacodynamics of
targeted early use of indomethacin for PDA treatment in preterm neonates <27 weeks'
gestational age.
Phase:
Phase 2
Details
Lead Sponsor:
University of Manitoba
Collaborators:
Health Sciences Centre, Winnipeg, Manitoba St. Boniface General Hospital Research Centre St. Boniface Hospital University at Buffalo